Buy Rating Affirmed for Day One Biopharmaceuticals on Strong Tovorafenib Prospects and ...

Retrieved on: 2024-04-22 17:36:18

Tags for this article:

Click the tags to see associated articles and topics

Buy Rating Affirmed for Day One Biopharmaceuticals on Strong Tovorafenib Prospects and .... View article details on HISWAI: https://markets.businessinsider.com/news/stocks/buy-rating-affirmed-for-day-one-biopharmaceuticals-on-strong-tovorafenib-prospects-and-market-impact-1033270908

Excerpt

Analyst Anupam Rama of J.P. Morgan maintained a Buy rating on Day One Biopharmaceuticals (DAWN – Research Report), boosting the price targ...

Article found on: markets.businessinsider.com

View Original Article